Clinical and Translational Science Award
Clinical and Translational Science Award
批准号:
10674531
负责人:
Muredach P Reilly
金额:
$1029.98万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2026-05-31
关键词:
AccelerationAddressCOVID-19 pandemicClinical ResearchClinical SciencesClinical Trials DesignClinical and Translational Science AwardsCollaborationsCommunitiesDentalEducationElectronic Health RecordEnvironmentEvaluationEvolutionFacultyFoundationsFriendsGoalsHealthHealth BenefitHealth systemHealthcareHospitalsInfrastructureInstitutionInterdisciplinary StudyLaboratoriesLeadLeadershipLearningMedical centerMedicineMethodsMissionModelingNew YorkNew York CityPatientsPersonal SatisfactionPhasePhysiciansPresbyterian ChurchProblem SolvingProcessProgram DevelopmentPublic HealthPublic Health SchoolsRecording of previous eventsResearchResearch MethodologyResearch PersonnelResourcesSchool NursingSchoolsScienceSpeedStrategic PlanningStrategic visionSurgeonTimeTrainingTranslational ResearchUniversitiesVisionWorkforce Developmentcareercollegedissemination scienceexperienceflexibilityimplementation scienceimprovedinnovationmeetingsmembernovelnovel therapeuticsoperationopioid epidemicprecision medicineprogramssuccesssynergismtranslational pipelineuser-friendly
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Contact PD/PI: Reilly, Muredach P
OVERALL: PROJECT SUMMARY/ABSTRACT
Our mission is to improve the health of our patients and communities both locally and nationally through
innovations in clinical and translational research. Our strategic vision is to catalyze all phases of clinical and
translational science (T0-T4), synergize with our partners and stakeholders, and integrate activities within our
hub and across the national Clinical and Translational Science Award (CTSA) Program. To achieve this vision,
we will build on our strong established track-record (e.g., in precision medicine), our plans to tackle important
public-health challenges (e.g., COVID-19 pandemic, the opioid crisis) and to address critical barriers (e.g.,
innovation in use of electronic health records for research, clinical trial designs) as we embrace the CTSA
Program priorities designated in PAR-18-940. Our vision is to transform the health and wellbeing of our
communities in New York City, the nation and the world. To achieve this, we deploy our programs and resources
to develop, demonstrate and disseminate innovations in
clinical and translational science
across the full
translational spectrum.
As a comprehensive CTSA, we offer a broad array of support for trainees, scholars and
investigators across our entire hub which includes Columbia University, the Columbia University Irving Medical
Center, the New York Psychiatric Institute, and New York Presbyterian Hospital. At the same time, we move
flexibly and deeply to address critical scientific or institutional opportunities as well as major public health needs
and gaps. We achieve success by approaching our goals at multiple levels: a) Ongoing strategic planning
including an annual retreat to review operations and identify gaps, needs and opportunities; b) Monthly cross-
cutting “Theme” meetings to enable collaborative problem-solving in addressing gaps and opportunities; c) An
innovative Evaluation and Continuous Improvement strategy using participatory management to integrate
evaluation into program planning and execution; and d) A highly successful, innovative interdisciplinary training
and workforce development program built on a foundation of team science. Central to our efforts to improve
health and wellbeing at personal, community and national levels is our emphasis on strategic collaboration and
dissemination. Thus, we seek to continuously create and refine innovations for an integrated research- and user-
friendly translational research environment at our hub by: Harnessing partnerships across our entire hub;
Transforming collaborations with our local communities, the campus health system and across New York State;
And by accelerating bidirectional dissemination of innovative practices and learnings through collaborations with
the CTSA Program network and beyond.
Project Summary/Abstract Page 221
Contact PD/PI: Reilly, Muredach P
Narrative
The Clinical and Translational Science Award (CTSA) allows Columbia University to support novel programs
whose goal is to speed the transition from scientific discoveries made in the laboratory toward new therapies.
Building on our strong established track-record, we will tackle important challenges and critical barriers to
research. We will facilitate the training of scholars from diverse backgrounds underrepresented in translational
science who are knowledgeable about and available to focus on translational science later in their careers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Smooth muscle cell-derived cell fates and cellular interactions in atherosclerotic plaque stability in disease progression and regression.
-
批准号:10567844
-
项目类别:
-
资助金额:$72.63万
-
财政年份:2023
-
负责人:Muredach P Reilly
-
依托单位:
Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease risk
-
批准号:10720225
-
项目类别:
-
资助金额:$69.24万
-
财政年份:2023
-
负责人:Muredach P Reilly
-
依托单位:
Human LincRNAs in Macrophage Biology and Related Cardiometabolic Diseases
-
批准号:9402855
-
项目类别:
-
资助金额:$72.21万
-
财政年份:2017
-
负责人:Muredach P Reilly
-
依托单位:
Human LincRNAs in Macrophage Biology and Related Cardiometabolic Diseases
-
批准号:9983136
-
项目类别:
-
资助金额:$66.47万
-
财政年份:2017
-
负责人:Muredach P Reilly
-
依托单位:
Human LincRNAs in Macrophage Biology and Related Cardiometabolic Diseases
-
批准号:9531432
-
项目类别:
-
资助金额:$70.36万
-
财政年份:2017
-
负责人:Muredach P Reilly
-
依托单位:
Clinical and Translational Science Award
-
批准号:10349079
-
项目类别:
-
资助金额:$1012.1万
-
财政年份:2016
-
负责人:Muredach P Reilly
-
依托单位:
Clinical and Translational Science Award
-
批准号:10439923
-
项目类别:
-
资助金额:$1016.28万
-
财政年份:2016
-
负责人:Muredach P Reilly
-
依托单位:
Clinical and Translational Science Award
-
批准号:9309130
-
项目类别:
-
资助金额:$934.07万
-
财政年份:2016
-
负责人:Muredach P Reilly
-
依托单位:
Clinical and Translational Science Award
-
批准号:10199125
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2016
-
负责人:Muredach P Reilly
-
依托单位:
Clinical and Translational Science Award
-
批准号:9932779
-
项目类别:
-
资助金额:$63.99万
-
财政年份:2016
-
负责人:Muredach P Reilly
-
依托单位:
Clinical and Translational Science Award
-
批准号:10792085
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2016
-
负责人:Muredach P Reilly
-
依托单位:
Translational Studies of ADAMTS7 a Novel GWAS Locus for Coronary Atherosclerosis
-
批准号:9266154
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2012
-
负责人:Muredach P Reilly
-
依托单位:
Translational Studies of ADAMTS7 a Novel GWAS Locus for Coronary Atherosclerosis
-
批准号:8875739
-
项目类别:
-
资助金额:$34.14万
-
财政年份:2012
-
负责人:Muredach P Reilly
-
依托单位:
Translational Studies of ADAMTS7 a Novel GWAS Locus for Coronary Atherosclerosis
-
批准号:8514059
-
项目类别:
-
资助金额:$59.35万
-
财政年份:2012
-
负责人:Muredach P Reilly
-
依托单位:
Translational Studies of ADAMTS7 a Novel GWAS Locus for Coronary Atherosclerosis
-
批准号:8371008
-
项目类别:
-
资助金额:$62.43万
-
财政年份:2012
-
负责人:Muredach P Reilly
-
依托单位:
Translational Studies of ADAMTS7 a Novel GWAS Locus for Coronary Atherosclerosis
-
批准号:8681506
-
项目类别:
-
资助金额:$59.76万
-
财政年份:2012
-
负责人:Muredach P Reilly
-
依托单位:
Glycomics of Heart and Lung Disease in the Genomic Era
-
批准号:8692484
-
项目类别:
-
资助金额:$59.22万
-
财政年份:2011
-
负责人:Muredach P Reilly
-
依托单位:
Fractalkine in Adipose Inflammation and Insulin Resistance
-
批准号:8184364
-
项目类别:
-
资助金额:$55.55万
-
财政年份:2011
-
负责人:Muredach P Reilly
-
依托单位:
Mentored Patient Oriented Research in Cardiometabolic Disease
-
批准号:8263968
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2011
-
负责人:Muredach P Reilly
-
依托单位:
Mentored Patient Oriented Research in Cardiometabolic Disease
-
批准号:8661254
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2011
-
负责人:Muredach P Reilly
-
依托单位:
海外基金